Publications by authors named "Jeffrey A Rappaport"

Claim this Profile
T
Time Toxicity of Cancer Care-A Call to Action.
Sahil D Doshi, Jeffrey A Rappaport, Erin M Bange

JAMA Netw Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy.
John C Flickinger, Ross E Staudt, Jagmohan Singh, Robert D Carlson, Joshua R Barton, Jeffrey A Rappaport

NPJ Vaccines· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer.
Jeffrey A Rappaport, Ariana A Entezari, Adi Caspi, Signe Caksa, Aakash V Jhaveri

Cell Mol Gastroenterol Hepatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
John C Flickinger, Jeffrey A Rappaport, Joshua R Barton, Trevor R Baybutt, Amanda M Pattison

Biomark Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer.
Jeffrey A Rappaport, Scott A Waldman

Expert Rev Clin Pharmacol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity.
John C Flickinger, Jagmohan Singh, Robert Carlson, Elinor Leong, Trevor R Baybutt, Jeffrey A Rappaport

J Immunother Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis.
Erik S Blomain, Jeffrey A Rappaport, Amanda M Pattison, Babar Bashir, Ellen Caparosa

Cancer Biol Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-Tocopherol Effect on Endocytosis and Its Combination with Enzyme Replacement Therapy for Lysosomal Disorders: A New Type of Drug Interaction?
Rachel L Manthe, Jeffrey A Rappaport, Yan Long, Melani Solomon, Vinay Veluvolu

J Pharmacol Exp Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.
Babar Bashir, Dante J Merlino, Jeffrey A Rappaport, Esteban Gnass, Juan P Palazzo

Hum Pathol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia.
Jeffrey A Rappaport, Scott A Waldman

Front Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GUCY2C maintains intestinal LGR5 stem cells by opposing ER stress.
Crystal L Kraft, Jeffrey A Rappaport, Adam E Snook, Amanda M Pattison, John P Lynch

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis